- UroToday Home
- Men's Health
The Latest BPH Research
Recent Abstracts
-
A Novel Nomogram Based on Initial Features to Predict BPH Progression.BPH - Benign Prostatic EnlargementAugust 15, 2022
-
Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk.BPH - Benign Prostatic EnlargementAugust 14, 2022
-
Clinical significance of distally located periurethral calcification in patients with lower urinary tract symptoms of benign prostate hyperplasia.BPH - Benign Prostatic EnlargementAugust 14, 2022
-
Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.BPH - Benign Prostatic EnlargementAugust 8, 2022
-
Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia.BPH - Benign Prostatic EnlargementAugust 7, 2022
-
The role of testosterone in men's health: is it time for a new approach?BPH - Benign Prostatic EnlargementAugust 7, 2022
-
Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases.BPH - Benign Prostatic EnlargementAugust 1, 2022
-
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study.BPH - Benign Prostatic EnlargementJuly 31, 2022
-
Evolution of healthcare costs for lower urinary tract symptoms associated with benign prostatic hyperplasia.BPH - Benign Prostatic EnlargementJuly 31, 2022
-
Comparison of Tamsulosin and Tadalafil effects in LUTS treatment considering patients' atherosclerosis risk level.BPH - Benign Prostatic EnlargementJuly 25, 2022
Beyond the Abstracts
-
Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates - Beyond the AbstractBPH - Benign Prostatic EnlargementAugust 3, 2022
-
Large, Multi-Center, Prospective Registry of Rezūm Water Vapor Therapy for Benign Prostatic Hyperplasia - Beyond the AbstractBPH - Benign Prostatic EnlargementMay 19, 2022
-
Efficacy and Tolerability of the Hexanic Extract of Serenoa Repens Compared to Tamsulosin in Moderate-Severe LUTS-BPH Patients - Beyond the AbstractBPH - Benign Prostatic EnlargementMarch 8, 2022
-
Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparison of Device Related Adverse Events in a National Registry - Beyond the AbstractBPH - Benign Prostatic EnlargementNovember 1, 2021
-
New Endoscopic In-Office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review - Beyond the AbstractBPH - Benign Prostatic EnlargementJuly 7, 2021
-
Possible Clinical Implications of Prostate Capsule Thickness and Glandular Epithelial Cell Density in Benign Prostate Hyperplasia - Beyond the AbstractBPH - Benign Prostatic EnlargementJuly 6, 2021
-
Improvement of Urinary Tract Symptoms and Quality of Life in Benign Prostate Hyperplasia Patients Associated with Consumption of a Newly Developed Whole Tomato-Based Food Supplement - Beyond the AbstractBPH - Benign Prostatic EnlargementJune 15, 2021
-
Real World Experience of Holmium Laser Enucleation of the Prostate with Patients on Anticoagulation Therapy - Beyond the AbstractBPH - Benign Prostatic EnlargementMarch 9, 2021
-
The Safety and Feasibility of the Simultaneous Use of 180-W GreenLight Laser for Prostate Vaporization During Concomitant Surgery - Beyond the AbstractBPH - Benign Prostatic EnlargementFebruary 26, 2021
-
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED - Beyond the AbstractBPH - Benign Prostatic EnlargementJanuary 21, 2021
